bioMerieux (Paris:BIM), a world leader in the field of in vitro diagnostics, provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety....Show all
Phone: 0 820 22 3000
5, rue des Aqueducs
Craponne, 69290
France
Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2020-06-11 | Accellix | Series D | $9.5M | |
2019-02-07 | Invisible Sentinel | Acquired | ||
2018-11-09 | Hybiome Biomedical | Corporate Majority | $186.11M | |
2018-04-04 | Astute Medical | Acquired | ||
2017-12-04 | Qvella | Series B | $20M | Hatteras Venture Partners, RA Capital Management, Sands Capital, and Whitecap Venture Partners |